CHST4 might promote the malignancy of cholangiocarcinoma
Guanran Zhang(Shandong University), Xiaoli Zhang(Shandong University), Xuyue Liu(Shandong University), Aiwen Jian(Chinese Academy of Medical Sciences & Peking Union Medical College), Jing Hao(Shandong University), Kexin Zheng(Shandong University), Haiyan Wang(Southern University of Science and Technology), Sujuan Zhi(Shandong University)
Cited by 1
Related Papers
Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19
|Journal of Allergy and Clinical Immunology|2020|694
Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome
|medRxiv|2020|274
Antibody Responses to SARS-CoV-2 in Patients of Novel Coronavirus Disease 2019
|SSRN Electronic Journal|2020|222
Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2
|Nature Communications|2021|146
TRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer
|Cell Death and Disease|2023|47